Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 11, 2024European Journal Of HaematologyOpen Access

Venetoclax‐based non‐intensive induction followed by allogenic stem‐cell transplantation in elderly acute myeloid leukemia patients with adverse cytogenetics

View Full Paper
Ask AI
Bookmark
Share

Authors

ASAmel SouaJGJulia GilhodesAIAlexandre Iat

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Soua et al. (2024) studied this question.

synapsesocial.com/papers/68e5cb6fb6db643587562231https://doi.org/10.1111/ejh.14290
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clinical Effects of Venetoclax in the Treatment of Acute Myeloid Leukemia in the Elderly2024
  2. 2Venetoclax Plus Azacitidine as a Bridge Treatment to Allogeneic Stem Cell Transplantation in Unfit Patients with Acute Myeloid Leukemia2024 · 6 citations
  3. 3Synergistic efficacy and preliminary molecular mechanisms of venetoclax combined with microtransplantation in the treatment of elderly patients with Acute Myeloid Leukemia2025
  4. 4Venetoclax and hypomethylating agents in octogenarians and nonagenarians with acute myeloid leukemia2024 · 17 citations
  5. 5Phase II trial of venetoclax in combination with azacitidine as maintenance therapy for high-risk acute leukemia following allogeneic stem cell transplantation2025